Detalhe da pesquisa
1.
A novel orally active gonadotropin-releasing hormone antagonist, relugolix, is a potential substitute for injectable GnRH antagonists in controlled ovarian stimulation in assisted reproductive technology.
Reprod Med Biol
; 21(1): e12424, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34938148